Product Name | lanraplenib |
Synonyms | lanraplenib;GS-SYK;A6U64OU57E;6-(6-Aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine;6-(6-aminopyrazin-2-yl)-N-{4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}imidazo[1,2-a]pyrazin-8-amine;6-(6-aminopyrazin-2-yl)-N-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine;Lanraplenib [INN];Lanraplenib [USAN];Lanraplenib [USAN:INN];GTPL9764;example 2 [US9290505];XCIGZBVOUQVIPI-UHFFFA;6-(6-amino-2-pyrazinyl)-N-[4-[4-(3-oxetanyl)-1-piperazinyl]phenyl]-imidazo[1,2-a] |
Catalog No. | A-2649 |
CAS No. | 1800046-95-0 |
Molecular Formula | C23H25N9O |
Molecular Weight | 443.504302740097 |
Smile Code | C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N |
InChI | |
EINECS | |
Density | |
Melting point | |
Boiling point | |
Refractive index | |
Water solubility | |
Hazard Symbols | |
Risk Codes | |
Safety Description |